Description: The coming wave of biosimilars could dramatically affect prescription drug costs and benefit strategies over the next several years. The launch of many Humira biosimilars in 2023 is the Big Event that will largely determine the impact of the biosimilar wave. Payers have many decisions to make about coverage and formulary tiers. What factors will drive payer decision-making?

Description: Similar to how states had made adjustments to their capitation rates to reflect acuity adjustments caused by the onset of the pandemic, states will need to modify the rates to reflect the unwinding since utilization patterns and average acuity per enrolled member will change. When the continuous coverage requirements set forth by the COVID-19 Public Health Emergency (PHE) ended, Medicaid-managed care programs across the country adopted various approaches to phasing out maintenance of effort (MOE) as a result of changes to the PHE-era continuous eligibility requirements. Phasing out the MOE requirement will ultimately result in members who no longer meet eligibility requirements losing their Medicaid coverage. Further, states are facing a wide variety of circumstances and are implementing diverse approaches to the MOE phase-out. This topic will be of significant interest to all actuaries and stakeholders of the capitation rate development process for Medicaid-managed care programs. Join us as we discuss the operationalization of the PHE unwind while referencing the SOA's research project which models the effects of the unwinding on Medicaid eligibility and population costs. You will learn about the various approaches that different states have adopted to manage the unwinding process, which will be instrumental for accurately pricing managed care rates.

Description: View the Impact of Covid-19 on the Socioeconomic Differential in Mortality in the United States.

Description: The recent round of regulatory changes (LDTI, IFRS 17, PBR) has put a demand on actuarial organizations, and in particular, financial reporting functions unlike most have experienced in their careers. With adoption, where does this leave the financial reporting function going forward? What work is left to be done? How will the financial reporting function need to evolve under these accounting regimes? Come explore these topics and more through a moderated debate, inclusive of the following questions: - What are the biggest 'day 2' items that remain on your organization's 'to-do' list? - How are valuation actuaries equipped to navigate the newly available data, understand the results, and tell the underlying earnings story? - How do new regulatory requirements fit into current close calendar requirements? - What are the peripheral impacts from regulatory change (e.g., FP&A, product development) and how are your valuation actuaries involved in these processes?

Description: Learn more about the concept of total risk analysis, which is designed to answer key questions as decisions are made.

Description: As AI becomes more pervasive, we must consider the potential repercussions and risks associated with its widespread use. The SOA seeks essays that delve into the multifaceted risks posed by (AI) over both the short and long term.

Description: The document is a research paper titled "Risk Analysis of the Causes of Food Deserts" authored by Lillian Wang, Audrey Hong, Jaden Chen, and Aaroh Tak for the Modeling the Future Challenge 2023-2024. It analyzes food desert risk factors, forecasts food desert rates, and proposes risk mitigation strategies based on statistical modeling and data analysis.

Description: In this session, industry leaders in both actuarial work and organization design/change management will focus on how the past three years have accelerated, changed, or slowed trends in the nature of actuarial work, particularly for larger-scale projects with a technology or development life-cycle component.

Description: Read the February 2024 issue of the Catastrophe & Climate strategic research program newsletter.